Halo Therapeutics

General Information

Company Name

Halo Therapeutics

Founded Year

2021

Location (Offices)

Bristol, United Kingdom +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology, Health Care, Health and Wellness +1

Funding Stage

Seed

Social Media

Halo Therapeutics - Company Profile

Halo Therapeutics is a DeepTech Health Company founded in 2020 and headquartered in the United Kingdom. The company's focus lies in the development of pan-coronavirus antivirals, positioning itself within the Biotechnology and Health Care industries. Notably, on 17 May 2023, it secured a significant £1.52M Seed Round investment from Development Bank of Wales, KBA Group, and Johnathan Matlock. As a startup committed to addressing global health challenges, Halo Therapeutics stands out as a compelling player in the biotech and healthcare landscape, with promising potential for investors.

Taxonomy: DeepTech, Health, Antivirals, Coronavirus, Pharmaceuticals, Medical Research, Drug Development, Innovation, Pandemic Response, Viral Infections, Biomedical Technology, Therapeutics, Public Health